Skip to content

The Characteristics of the Capital-Clinical study of Guben quyu jiedu capsule for chronic obstructive pulmonary disease and sleep apnea

The Characteristics of the Capital-Clinical study of Guben quyu jiedu capsule for chronic obstructive pulmonary disease and sleep apnea

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16007768
Enrollment
Unknown
Registered
2016-01-14
Start date
2016-03-02
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease with sleep apnea

Interventions

treatment group:based treatments+Guben quyu jiedu Decoction

Sponsors

Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with chronic obstructive pulmonary disease and sleep apnea hypopnea syndrome and the severity is Mild and moderate according to GOLD; 2. meet the Chinese medicine diagnosis standard of Stagnation of blood and evil factors in meridian; 3. In past two years the COPD acute episodes < 2 times per year; 4. Aged 30 to 75 years old; 5. participants voluntarily accept this kind of treatment, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. On the abnormal anatomy of the airway; 2. Pregnancy or planning a pregnancy or breast-feeding women; 3. With asthma, bronchiectasis, malignant tumor and blood disease patients; 4. Participated in other clinical subjects within three months; 5. Heart, liver and kidney function for severe damage; 6. Complicated with serious primary diseases and immunocompromised disorders such as psychiatric patients; cardiovascular diseases; 7. Congenital or acquired immunodeficiency; 8. Have allergy history of medicine composition.

Design outcomes

Primary

MeasureTime frame
apnea hyponea index;The lowest oxygen saturation at night;oxygen desaturation index;

Countries

China

Contacts

Public ContactWenjiang Zhang
zwj-hcy@sohu.com+86 13611391576

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026